Pertussis is an endemic disease in the EU/EEA and worldwide. Every three to five years, larger epidemics are expected even with high vaccination coverage.
This document assesses the risk associated with the dissemination of carbapenemase-producing hypervirulent Klebsiella pneumoniae (hvKp) of sequence type (ST) 23 and other STs in the European Union/European Economic Area (EU/EEA).
This report presents the available data for describing the current situation regarding HIV prevalence among sex workers, and the efforts being made across Europe and Central Asia towards HIV prevention among this population.
The Global Influenza Surveillance and Response System (GISRS), led by WHO, is used for the international virological and epidemiological surveillance of human influenza.
The clinical surveillance of influenza in the European Influenza Surveillance Network (EISN) is generally based on reports made by sentinel general practitioners. Some of the sentinel surveillance systems also include paediatricians and physicians with other specialisations. The physicians usually represent 1-5% of physicians working in the country or region.
There are general objectives for integrated surveillance of respiratory viruses in the European Union. These objectives apply to surveillance of influenza, COVID-19, and other respiratory virus infections.
Outsourced microbiological support to hospital-based surveillance of CDI aims to increase the capacity of laboratories in EU/EEA Member States to perform diagnostic practices with high diagnostic accuracy and acquire comparable typing data from C. difficile isolates.